{"id":"https://openalex.org/W2133197823","doi":"https://doi.org/10.3317/jraas.2004.032","title":"Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor \u03b21, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat","display_name":"Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor \u03b21, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat","publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W2133197823","doi":"https://doi.org/10.3317/jraas.2004.032","mag":"2133197823","pmid":"https://pubmed.ncbi.nlm.nih.gov/15526251"},"language":"en","primary_location":{"id":"doi:10.3317/jraas.2004.032","doi":"https://doi.org/10.3317/jraas.2004.032","is_oa":false,"landing_page_url":"https://doi.org/10.3317/jraas.2004.032","pdf_url":null,"source":{"id":"https://openalex.org/S107472416","display_name":"Journal of the Renin-Angiotensin-Aldosterone System","issn_l":"1470-3203","issn":["1470-3203","1752-8976"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Renin-Angiotensin-Aldosterone System","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/ba1d4183ba6e430b9e4ba911551dd7e7","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111462776","display_name":"Arie Erman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Arie Erman","raw_affiliation_strings":["Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel,","Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel, aerman@clalit.org.il#N#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel,","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]},{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel, aerman@clalit.org.il#N#","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067640608","display_name":"Semyon Veksler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Semyon Veksler","raw_affiliation_strings":["Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060849682","display_name":"Uzi Gafter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Uzi Gafter","raw_affiliation_strings":["Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037629350","display_name":"Geoffrey Boner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Geoffrey Boner","raw_affiliation_strings":["Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008346797","display_name":"Clara Wittenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Clara Wittenberg","raw_affiliation_strings":["Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049899015","display_name":"David Jonathan van Dijk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2800389475","display_name":"Rabin Medical Center","ror":"https://ror.org/01vjtf564","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2800389475","https://openalex.org/I64767286"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"David Jonathan van Dijk","raw_affiliation_strings":["Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv Israel","institution_ids":["https://openalex.org/I16391192","https://openalex.org/I2800389475"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.1139,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.78866868,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"5","issue":"3","first_page":"146","last_page":"151"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0551999993622303,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-angiotensin-system-blockade","display_name":"renin-angiotensin system blockade","score":0.9779999852180481},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.9300000071525574},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.9900000095367432},{"id":"https://openalex.org/keywords/renal-hypertrophy","display_name":"renal hypertrophy","score":0.9779999852180481},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.8899999856948853},{"id":"https://openalex.org/keywords/enalapril","display_name":"enalapril","score":1.0},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.6769999861717224},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.9850000143051147},{"id":"https://openalex.org/keywords/serum-ace-activity","display_name":"serum ACE activity","score":0.6290000081062317},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.9067944288253784},{"id":"https://openalex.org/C2775940317","wikidata":"https://www.wikidata.org/wiki/Q422185","display_name":"Enalapril","level":4,"score":0.8131565451622009},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7431477904319763},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.74077969789505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6631284356117249},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.6426957845687866},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.5236917734146118},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.5050895810127258},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4768877327442169},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.4454447329044342},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.3990349769592285},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.38407325744628906},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.3521595895290375},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15758690237998962},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.10870975255966187}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004656","descriptor_name":"Enalapril","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006984","descriptor_name":"Hypertrophy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3317/jraas.2004.032","doi":"https://doi.org/10.3317/jraas.2004.032","is_oa":false,"landing_page_url":"https://doi.org/10.3317/jraas.2004.032","pdf_url":null,"source":{"id":"https://openalex.org/S107472416","display_name":"Journal of the Renin-Angiotensin-Aldosterone System","issn_l":"1470-3203","issn":["1470-3203","1752-8976"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Renin-Angiotensin-Aldosterone System","raw_type":"journal-article"},{"id":"pmid:15526251","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15526251","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the renin-angiotensin-aldosterone system : JRAAS","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.505.4","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.505.4","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jra.sagepub.com/content/5/3/146.full.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:ba1d4183ba6e430b9e4ba911551dd7e7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ba1d4183ba6e430b9e4ba911551dd7e7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the Renin-Angiotensin-Aldosterone System, Vol 5 (2004)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:ba1d4183ba6e430b9e4ba911551dd7e7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ba1d4183ba6e430b9e4ba911551dd7e7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the Renin-Angiotensin-Aldosterone System, Vol 5 (2004)","raw_type":"article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W198509040","https://openalex.org/W991396004","https://openalex.org/W1964947325","https://openalex.org/W1971823155","https://openalex.org/W1974466887","https://openalex.org/W1979741702","https://openalex.org/W1980295850","https://openalex.org/W1996413553","https://openalex.org/W2009729476","https://openalex.org/W2016126193","https://openalex.org/W2017475990","https://openalex.org/W2021973626","https://openalex.org/W2045081700","https://openalex.org/W2045790461","https://openalex.org/W2056976690","https://openalex.org/W2065860622","https://openalex.org/W2071361393","https://openalex.org/W2079306975","https://openalex.org/W2083008696","https://openalex.org/W2084343172","https://openalex.org/W2093809876","https://openalex.org/W2098154750","https://openalex.org/W2104492320","https://openalex.org/W2108140227","https://openalex.org/W2111683333","https://openalex.org/W2116520916","https://openalex.org/W2118279423","https://openalex.org/W2128635872","https://openalex.org/W2137946319","https://openalex.org/W2141120643","https://openalex.org/W2149496619","https://openalex.org/W2160934553","https://openalex.org/W2341569738","https://openalex.org/W2403786572","https://openalex.org/W2413810750","https://openalex.org/W2615684303","https://openalex.org/W4252385249"],"related_works":["https://openalex.org/W2108140227","https://openalex.org/W2374218675","https://openalex.org/W7096693327","https://openalex.org/W2088745874","https://openalex.org/W2058173334","https://openalex.org/W2391944188","https://openalex.org/W2170609859","https://openalex.org/W2044617739","https://openalex.org/W2914627019","https://openalex.org/W1964290300"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Combination":[1,217],"therapy":[2,72,175,218],"with":[3,28,159,205,211,219,228,239],"angiotensin-converting":[4],"enzyme":[5],"(ACE)":[6],"inhibitors":[7],"and":[8,35,77,133,149,195,210,221],"angiotensin":[9],"receptor":[10],"blockers":[11],"(ARBs)":[12],"is":[13],"used":[14],"to":[15,54,93,250,266],"improve":[16],"renal":[17],"outcome":[18],"achieved":[19],"by":[20,62,70],"monotherapy":[21,68,184,227],"in":[22,45,81,154,193,196,231,264],"diabetic":[23,46,82,102,110,120,128,156],"patients.":[24],"In":[25],"addition,":[26],"interference":[27],"the":[29,56,60,245,256],"renin-angiotensin":[30],"system":[31],"(RAS)":[32],"reduced":[33,267],"expression":[34],"excretion":[36,214],"of":[37,50,58,162],"transforming":[38],"growth":[39],"factor":[40],"beta":[41],"1":[42,80,96,200],"(TGF-beta":[43],"1)":[44],"nephropathy.":[47],"The":[48,135,258],"aim":[49],"this":[51],"study":[52,136],"was":[53,223,241],"investigate":[55],"effects":[57],"interrupting":[59],"RAS":[61],"ACE":[63,147,190],"inhibitor":[64],"(ACE-I)":[65],"or":[66,69,165],"ARB":[67],"combination":[71],"on":[73,255],"proteinuria,":[74],"kidney":[75,144],"hypertrophy":[76],"plasma":[78,150],"TGF-beta":[79,199,268],"rats.":[83],"MATERIALS":[84],"AND":[85],"METHODS:":[86],"Forty-one":[87],"male":[88],"Wistar":[89],"rats":[90,103,111,121,129,157],"were":[91,202],"allocated":[92],"five":[94],"groups:":[95],"=":[97,101,109,119,127],"control":[98],"rats,":[99],"2":[100],"(streptozotocin":[104],"[STZ]":[105],"55":[106],"mg/kg),":[107],"3":[108],"as":[112,242,244],"above":[113],"receiving":[114,122,130],"enalapril":[115,222],"(20":[116],"mg/kg/day),":[117,125],"4":[118],"losartan":[123,132,220,240],"(80":[124],"5":[126],"both":[131,166,192],"enalapril.":[134],"lasted":[137],"60":[138,168],"days.":[139],"RESULTS:":[140],"Urinary":[141],"protein":[142,181,213],"excretion,":[143,182],"weight,":[145],"serum":[146,189],"activity":[148,191],"TGF-beta1":[151],"increased":[152],"significantly":[153],"untreated":[155],"compared":[158],"controls.":[160],"Administration":[161],"losartan,":[163],"enalapril,":[164],"for":[167,176],"days":[169,178],"prevented":[170],"these":[171],"changes.":[172],"Furthermore,":[173],"combined":[174,246],"30":[177],"normalised":[179],"urinary":[180,212],"while":[183],"did":[185],"not.":[186],"Losartan":[187],"inhibited":[188],"vivo":[194],"vitro.":[197],"Plasma":[198],"levels":[201,208],"positively":[203],"correlated":[204],"blood":[206],"glucose":[207],"(r=0.4059)":[209],"(r=0.3558).":[215],"CONCLUSIONS:":[216],"more":[224],"effective":[225,243],"than":[226],"either":[229],"drug":[230],"achieving":[232],"an":[233],"early":[234],"antiproteinuric":[235,259],"response.":[236],"Long-term":[237],"treatment":[238],"treatment,":[247],"possibly":[248],"due":[249],"a":[251],"dual":[252],"inhibitory":[253],"effect":[254,260],"RAS.":[257],"may":[261],"be":[262],"related,":[263],"part,":[265],"1.":[269]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}